Cite
MLA Citation
J. Setton et al.. “CDK12 loss leads to replication stress and sensitivity to combinations of the ATR inhibitor camonsertib (RP-3500) with PARP inhibitors.” European journal of cancer, vol. 174, n.d., pp. S99–S100. http://access.bl.uk/ark:/81055/vdc_100169168811.0x00003a